Referring Physicians >> Newsletters >> September 2012 Liver Newsletter >> Clinical Research: Open Liver Trials
A sample of our open liver trials currently recruiting at the University of Wisconsin Carbone Cancer Center.
The purpose of this study is to see if adding the oral chemotherapy pill, sorafenib (Nexavar), to localized chemotherapy (chemoembolization) to the liver will help patients to live longer than treatment with localized chemotherapy to the liver without sorafenib.
This randomized phase III trial is studying sorafenib tosylate and doxorubicin hydrochloride to see how well they work compared with sorafenib tosylate alone in treating patients with locally advanced or metastatic liver cancer.
For a list of ALL open liver focused protocols available at the UW Carbone Cancer Center, please click here
For more information on how to participate or enroll a patient in a clinical trial at the UW Carbone Cancer Center, please click here